Zobrazeno 1 - 10
of 30
pro vyhledávání: '"Dina Averbuch"'
Autor:
Olaf Penack, Gloria Tridello, Urpu Salmenniemi, Rodrigo Martino, Nina Khanna, Katia Perruccio, Franca Fagioli, Monika Richert-Przygonska, Hélène Labussière-Wallet, Johan Maertens, Charlotte Jubert, Mahmoud Aljurf, Herbert Pichler, Gergely Kriván, Desiree Kunadt, Marina Popova, Melissa Gabriel, Elisabetta Calore, Igor Wolfgang Blau, Fabio Benedetti, Maija Itäla-Remes, Elizabeth de Kort, Domenico Russo, Maura Faraci, Anne-Lise Ménard, Peter von dem Borne, Xavier Poiré, Akif Yesilipek, Jolanta Gozdzik, Zeynep Arzu Yeğin, Lucrecia Yañez, Luca Facchini, Gwendolyn Van Gorkom, Lorenz Thurner, Ulker Kocak, Antònia Sampol, Tsila Zuckerman, Marc Bierings, Stephan Mielke, Fabio Ciceri, Lotus Wendel, Nina Knelange, Malgorzata Mikulska, Dina Averbuch, Jan Styczynski, Rafael de la Camara, Simone Cesaro
Publikováno v:
EClinicalMedicine, Vol 67, Iss , Pp 102393- (2024)
Summary: Background: Infections are the main reason for mortality during acute leukaemia treatment and invasive aspergillosis (IA) is a major concern. Allogeneic stem cell transplantation (alloSCT) is a standard therapy and often is the only live-sav
Externí odkaz:
https://doaj.org/article/e5d255140f7b46d3b99bf2de109b8e3d
Autor:
Irina Zaidman, Ehud Even-Or, Elroee Aharoni, Dina Averbuch, Yael Dinur-Schejter, Adeeb NaserEddin, Mordechai Slae, Bella Shadur, Polina Stepensky
Publikováno v:
Frontiers in Pediatrics, Vol 11 (2023)
BackgroundHematopoietic stem cell transplantation (HSCT) is the only curative option for many nonmalignant hematopoietic-derived diseases in pediatric patients. Survival after HSCT has improved in recent years and resulted in a 90% survival rate and
Externí odkaz:
https://doaj.org/article/5686bde0f1354afe9f086434e02bf8c4
Autor:
Tamar Ruth Gal Etzioni, Nurit Fainshtain, Adi Nitzan-Luques, Gal Goldstein, Sigal Weinreb, Violeta Temper, Maya Korem, Dina Averbuch
Publikováno v:
Microorganisms, Vol 12, Iss 1, p 145 (2024)
Invasive fungal infections (IFI) cause morbidity and mortality in children with acute leukemia (AL). We retrospectively collected data on febrile neutropenic episodes (FNE) in AL children (2016–2021) and assessed factors associated with proven/prob
Externí odkaz:
https://doaj.org/article/e2648022573049f68e48a4bc122e3c98
Publikováno v:
Journal of Fungi, Vol 9, Iss 12, p 1171 (2023)
Candida spp. can cause bloodstream infection and is associated with significant mortality. The proportion of fluconazole-resistant Candida non-albicans has increased over the years, and empirical fluconazole maybe inappropriate. In this retrospective
Externí odkaz:
https://doaj.org/article/7961f52d37e84df6a53441aa87ac50f3
Autor:
Peter Dreger, Nathalie Fegueux, Urban Novak, Jakob R Passweg, Christian Chabannon, Arnold Ganser, Edouard Forcade, Rafael de la Cámara, Grzegorz W Basak, Christian Koenecke, Urs Schanz, Olaf Penack, Christophe Peczynski, Emmanuelle Polge, Andrea Kuhnl, Michael Daskalakis, Nicolaus Kröger, Caroline Besley, Adrian Bloor, Lucia López Corral, Ivan Moiseev, Hélène Schoemans, Anna Sureda, Dina Averbuch, Bertram Glass, Zinaida Peric
Publikováno v:
Journal for ImmunoTherapy of Cancer, Vol 11, Iss 4 (2023)
We investigated the incidence and outcome of anti-CD19 chimeric antigen receptor (CAR) T-cells-associated Common Terminology Criteria for Adverse Events (CTCAE) ≥grade 3 cytopenia. In the EBMT CAR-T registry, we identified 398 adult patients with l
Externí odkaz:
https://doaj.org/article/671c0329917e4b598b9bb0701331071d
Autor:
Per Ljungman, Gloria Tridello, Jose Luis Piñana, Fabio Ciceri, Henrik Sengeloev, Alexander Kulagin, Stephan Mielke, Zeynep Arzu Yegin, Matthew Collin, Sigrun Einardottir, Sophie Ducastelle Lepretre, Johan Maertens, Antonio Campos, Elisabetta Metafuni, Herbert Pichler, Frantisek Folber, Carlos Solano, Emma Nicholson, Meltem Kurt Yüksel, Kristina Carlson, Beatriz Aguado, Caroline Besley, Jenny Byrne, Immaculada Heras, Fiona Dignan, Nicolaus Kröger, Christine Robin, Anjum Khan, Stig Lenhoff, Anna Grassi, Veronika Dobsinska, Nuno Miranda, Maria-Jose Jimenez, Ipek Yonal-Hindilerden, Keith Wilson, Dina Averbuch, Simone Cesaro, Alienor Xhaard, Nina Knelange, Jan Styczynski, Malgorzata Mikulska, Rafael de la Camara
Publikováno v:
Frontiers in Immunology, Vol 14 (2023)
IntroductionCOVID-19 has been associated with high morbidity and mortality in allogeneic hematopoietic stem cell transplant (allo-HCT) recipients.MethodsThis study reports on 986 patients reported to the EBMT registry during the first 29 months of th
Externí odkaz:
https://doaj.org/article/34d0341b3015429d8b862b7e7130e615
Autor:
Irina Zaidman, Tamar Shaziri, Dina Averbuch, Ehud Even-Or, Yael Dinur-Schejter, Adeeb NaserEddin, Rebecca Brooks, Bella Shadur, Aharon Gefen, Polina Stepensky
Publikováno v:
Frontiers in Pediatrics, Vol 10 (2022)
BackgroundAllogeneic hematopoietic stem cell transplantation (HSCT) is an efficient treatment for numerous malignant and nonmalignant conditions affecting children. This procedure can result in infectious and noninfectious neurological complications
Externí odkaz:
https://doaj.org/article/22b74a28384544a5aeb9e1ca75d0bbfd
Autor:
Dina Averbuch, Rafael de la Camara, Gloria Tridello, Nina Simone Knelange, Tatiana A. Bykova, Marianne Ifversen, Veronika Dobsinska, Mouhab Ayas, Amir Ali Hamidieh, Herbert Pichler, Antonio Perez-Martinez, Simone Cesaro, Mikael Sundin, Isabel Badell, Peter Bader, Jan-Erik Johansson, Oana Mirci-Danicar, Petr Sedlacek, Catherine Paillard, Brenda Gibson, Sarah Lawson, Nicolaus Kroeger, Selim Corbacioglu, Malgorzata Mikulska, Jose Luis Piñana, Jan Styczynski, Per Ljungman
Publikováno v:
Bone Marrow Transplantation. 58:558-566
Autor:
Raffaella Greco, John A. Snowden, Nina Simone Knelange, Gloria Tridello, Carlotta Cacciatore, Alienor Xhaard, Fabio Ciceri, Matthew Collin, Christelle Ferra, Ann De Becker, Manuela Badoglio, Dina Averbuch, Tobias Alexander, Per Ljungman, Rafael De la Camara
Hematopoietic stem cell transplant (HSCT) recipients may be at high risk of mortality from coronavirus disease 2019 (COVID-19). However, specific data on COVID-19 after treatment with HSCT in patients affected by autoimmune diseases (ADs) are still l
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::30e480412cd69b35fd22ffba40998f85
https://doi.org/10.1016/j.jaut.2023.103024
https://doi.org/10.1016/j.jaut.2023.103024
Autor:
Jukka Kanerva, Fanny Lanternier, Monica A. Slavin, Elio Castagnola, Andreas H. Groll, Dina Averbuch, Alessio Mesini, Roland A. Ammann, Carolina Garcia-Vidal, Simone Cesaro, Malgorzata Mikulska, Nicole Ritz, Jan Styczyński, Dorothea Pana, Adilia Warris, Thomas Lehrnbecher
Publikováno v:
The Lancet Oncology. 22:e270-e280
Paediatric patients with cancer and those undergoing haematopoietic cell transplantation are at high risk of bacterial infections. The 8th European Conference on Infections in Leukaemia (ECIL-8) convened a Paediatric Group to review the literature an